Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
LI ›
LIBZORIX
Trademark search for:
LIBZORIX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-06-27 — Application filed
2014-07-01 — Application filed
2014-07-03 — Application filed
2014-09-04 — Assigned to examiner
2014-09-12 — Approved for pub - principal register
2014-10-01 — Notification of notice of publication e-mailed
2014-10-21 — Published for opposition
2014-10-21 — Official gazette publication confirmation e-mailed
2014-12-16 — Noa e-mailed - sou required from applicant
2015-05-22 — Sou teas extension received
2015-05-22 — Sou extension 1 filed
2015-05-22 — Sou extension 1 granted
2015-05-26 — Notice of approval of extension request e-mailed
2015-06-08 — Teas change of correspondence received
2015-11-20 — Sou teas extension received
2015-11-20 — Sou extension 2 filed
2015-12-19 — Case assigned to intent to use paralegal
2015-12-19 — Sou extension 2 granted
2015-12-22 — Notice of approval of extension request e-mailed
2016-05-24 — Sou teas extension received
2016-05-24 — Sou extension 3 filed
2016-06-28 — Case assigned to intent to use paralegal
2016-06-29 — Sou extension 3 granted
2016-06-30 — Notice of approval of extension request e-mailed
2016-12-15 — Sou teas extension received
2016-12-15 — Sou extension 4 granted
2016-12-15 — Sou extension 4 filed
2016-12-17 — Notice of approval of extension request e-mailed
2017-06-16 — Sou teas extension received
2017-06-16 — Sou extension 5 filed
2017-06-20 — Sou extension 5 granted
2017-06-21 — Notice of approval of extension request e-mailed
2017-12-05 — Teas post publication amendment received
2017-12-05 — Notice of allowance cancelled
2017-12-07 — 1(b) basis deleted; proceed to registration
2017-12-08 — On hold - electronic record review required
2018-03-08 — Electronic record review complete
2018-04-10 — Registered-principal register
2022-08-03 — Attorney/dom.rep.revoked and/or appointed
2022-08-03 — Teas change of domestic representatives address
2022-08-03 — Teas change of owner address received
2022-08-03 — Teas change of correspondence received
2022-08-03 — Applicant/correspondence changes (non-responsive) entered
2022-08-03 — Teas revoke/app/change addr of atty/dom rep received
2022-08-03 — Teas withdrawal of attorney received-firm retains
2023-04-10 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-10-25 — Cancelled sec. 8 (6-yr)
2024-10-25 — Final status recorded
Owner Information
GlaxoSmithKline Biologicals S.A.
GlaxoSmithKline Biologicals S.A.
GlaxoSmithKline Biologicals S.A.
Correspondent
Christopher M. Hanes GSK
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
